Angela Davis
Dermatology · Sugar Land, TXNPI 1487672754
Payments from drug & device makers
Across 147 payments — averaging $28.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Incyte Corporation$444
- Sun Pharmaceutical Industries Inc.$389
- Pfizer$352
- Johnson & Johnson$323
- Mayne Pharma Commercial LLC$309
- AbbVie$306
- plus $2K from 17 others
What the payments were for
- Food & beverage$4,04798%
- Education$952%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Incyte Corporation | 8 | $444 |
| Sun Pharmaceutical Industries Inc. | 11 | $389 |
| Pfizer | 8 | $352 |
| Johnson & Johnson | 13 | $323 |
| Mayne Pharma Commercial LLC | 18 | $309 |
| AbbVie | 20 | $306 |
| Galderma Laboratories, L.p. | 10 | $294 |
| EPI Health, LLC | 5 | $281 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 11 | $253 |
| VYNE Pharmaceuticals Inc. | 13 | $250 |
| E.r. Squibb & Sons, L.L.C. | 3 | $136 |
| Novartis | 2 | $126 |
| Regeneron Healthcare Solutions, Inc. | 5 | $107 |
| LEO Pharma Inc. | 3 | $98 |
| Sanofi | 4 | $90 |
| UCB, Inc. | 2 | $77 |
| Amgen | 3 | $70 |
| Stemline Therapeutics Inc. | 1 | $57 |
| Almirall LLC | 3 | $55 |
| Boehringer Ingelheim | 1 | $51 |
| Arcutis Biotherapeutics, Inc. | 1 | $42 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Sitavig$190
- Cloderm$190
- Minolira 105mg$190
- Minolira 135mg$190
- Rhofade$190
- OPZELURA$129
- Winlevi$125
- Sotyktu$122
- DUOBRII$105
How this compares
$4,142 in reported general payments places this provider in the 45th percentile of 1,098 dermatology providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 35 | $2,763 |
| Fluorouracil | 27 | $1,186 |
| Doxycycline Monohydrate | 32 | $803 |
| Halobetasol Propionate | 19 | $599 |
| Clindamycin Phosphate | 26 | $584 |
| Alclometasone Dipropionate | 20 | $497 |
| Minoxidil | 31 | $445 |
| Ketoconazole | 35 | $426 |
| Mupirocin | 18 | $121 |
| Ammonium Lactate | 11 | $90 |
| Hydrocortisone | 22 | $70 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Sugar Land
- Vandana MadkanSugar Land$1.8M
- Stephen TyringWebster$14.1M
- Edward LainAustin$12M
- Mark LeeSan Antonio$10.9M
- John BrowningSan Antonio$10.7M
- Craig TellerBellaire$7.7M
- Patricia LeeWebster$7.2M
- Jennifer CatherDallas$4.9M
- Michael MigdenHouston$3.7M
- Martin MenterDallas$3.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.